市场调查报告书
商品编码
1403383
2030 年微球市场预测:按产品类型、原料、应用和地区分類的全球分析Microspheres Market Forecasts to 2030 - Global Analysis By Product Type, Raw Material, Application and By Geography |
根据Stratistics MRC的数据,2023年全球微球市场规模为24亿美元,预计到2030年将达到60.8亿美元,预测期内复合年增长率为14.2%。
微球是小球形颗粒,直径通常为 1 至 1000 微米 (μm)。它们通常由多种材料製成,包括聚合物、玻璃、陶瓷和金属。微球广泛应用于医学、製药、化妆品、材料科学等各领域。此外,微球的小尺寸和均匀的形状使它们对于精密应用很有价值,并且它们的多功能性使它们能够针对广泛行业中的特定功能进行客製化。
根据 OECD 的数据,2021 年美国医疗保健支出将占国内生产总值(GDP) 的 17.8%,而 2020 年为 18.8%。
医疗保健需求不断增长
微球用于各种医疗应用,以发挥药物输送的功能。在医学影像中,它也用作显影剂以帮助视力和诊断,在再生医学中,它有助于组织工程和细胞培养。此外,对微创手术和个人化医疗的日益重视增加了医疗保健行业对微球的需求,从而推动了市场扩张。
初始成本高
特别是在生产生物相容性或生物分解性的微球时,由于製造过程困难和特殊材料的使用,生产成本可能会增加。这些令人望而却步的费用可能会导致含有微球的药物和医疗程序的成本增加,从而限制了患者的可及性和负担能力。此外,经济负担可能会阻止小规模生产商进入市场,限制基于微球的创意医疗解决方案的进步,并阻碍市场成长。
生态学稳定的进展
随着医疗保健行业越来越关注永续性,微球提供了一种解决方案,可以最大限度地减少医疗保健对环境的影响。生物分解性微球应用于永续包装解决方案,以减少各种产品的环境足迹。此外,研究和开发工作的重点是利用可再生资源创建微球,有助于实现生态系统稳定的整体目标。随着生态考量成为商业策略的组成部分,它们的采用将推动该市场的成长。
缺乏意识和标准化
也缺乏在各种医疗应用中使用微球的标准化指南,这可能会影响患者的安全和结果。这种缺乏统一性对监管合规性和品质保证造成了障碍,导致利用率不足和错失为患者提供更好护理的机会。此外,製造商对将微球纳入其产品的潜在好处的认识有限,可能会导致错失创新和效率提高的机会,从而阻碍市场规模。
COVID-19 的爆发在多个方面对微球市场产生了负面影响。供应链中断、旅行限制和劳动力短缺给微球製造商带来了营运挑战。由于消费者支出和建设计划的减少,对广泛用于汽车、化妆品和建设产业的微球的需求有所下降。此外,医疗保健行业的收紧以及微球相关手术的搁置逐渐阻碍了该市场的成长。
预计中空部分在预测期内将是最大的
据估计,中空段占最大份额。中空球密度低,因此它们在混凝土和油漆等中用作轻质填充材。它广泛应用于石油和天然气、油漆和涂料、复合材料以及减轻重量以提高强度重量比的材料等多种行业。此外,在医疗应用中,中空微球在成像技术中用作显影剂,提高诊断过程中的可视性。
预计粉煤灰领域在预测期内的复合年增长率最高。
预计粉煤灰细分市场在预测期内的复合年增长率最高。粉煤灰微球可作为混凝土中的轻质填充材,提高强度、耐用性和绝缘性。飞灰微球由于其润滑性和浮力特性而被用于石油和天然气工业的钻井液中。此外,粉煤灰微球市场符合永续实践,因为它将工业废弃物(粉煤灰)回收为有价值的材料,从而有助于减少废弃物和环境保护,使该领域正在推动成长。
该地区处于尖端医疗创新和研究的前沿,开拓了各种医疗应用的创新微球技术。个人化医疗、精准药物输送以及生物相容性和生物分解性微球的开发都是其中的一些进步。此外,欧洲的技术突破带来了严格的品质标准和监管法规,推动了该地区的成长。
预计亚太地区在预测期内复合年增长率最高。各国政府正在製定计划和政策,鼓励使用和探索基于微球的医疗保健创新。中国和印度等国家越来越多地在基础设施计划的轻质混凝土中采用微球。该地区拥有致力于永续医疗保健解决方案和技术进步的主要企业,例如西门子医疗公司(Siemens Healthineers AG)、3M、吴羽公司(Kureha Corporation) 和Potters Industries LLC,这些公司正在推动该地区的成长。
According to Stratistics MRC, the Global Microspheres Market is accounted for $2.40 billion in 2023 and is expected to reach $6.08 billion by 2030 growing at a CAGR of 14.2% during the forecast period. Microspheres are tiny spherical particles with diameters typically ranging from 1 to 1000 micrometers (μm). They are often made from various materials, including polymers, glass, ceramics, and metals. Microspheres find extensive use in various fields, such as medicine, pharmaceuticals, cosmetics, and materials science. Furthermore, the small size and uniform shape of microspheres make them valuable for precise applications, and their versatility allows them to be customized for specific functions in a wide range of industries.
According to the OECD, the healthcare expenditure accounted for 17.8% of United States' gross domestic product (GDP) in 2021, compared to 18.8% in 2020.
Microspheres are used in many different medical applications as they perform the role of drug delivery vehicles, allowing for the regulated release of medications, improving the effectiveness of treatment, and minimizing negative effects. In medical imaging, these are also used as contrast agents to help with vision and diagnosis, as they facilitate tissue engineering and cell culture in regenerative medicine. Furthermore, the need for microspheres in the healthcare industry is increasing because of the growing emphasis on minimally invasive procedures and personalized medicine, which are driving this market expansion.
Production costs may rise as a result of difficult manufacturing procedures and the use of specialty materials, particularly when creating biocompatible or biodegradable microspheres. These outrageous expenses may consequently raise the cost of microsphere-containing medications or medical procedures, limiting patient accessibility and affordability. Furthermore, the financial strain could discourage smaller producers from entering the market and restrict the advancement of creative healthcare solutions based on microspheres, which hampers market growth.
Microspheres provide solutions that minimize the environmental impact of medical treatments as the healthcare industry places an increasing emphasis on sustainability. Biodegradable microspheres find applications in sustainable packaging solutions, reducing the environmental footprint of various products. Furthermore, research and development efforts are focused on creating microspheres from renewable resources, contributing to the overall goal of achieving ecological stability. As ecological considerations become integral to business strategies, the adoption of these will drive this market's growth.
Standardized guidelines for the use of microspheres in various medical applications are also lacking, which could have an impact on patient safety and outcomes. This lack of uniformity can create hurdles in regulatory compliance and quality assurance, resulting in inadequate utilization and lost chances to provide patients with better care. Moreover, the limited awareness among manufacturers about the potential advantages of incorporating microspheres in their products may result in missed opportunities for innovation and efficiency improvements, thereby hampering this market size.
The COVID-19 pandemic has adversely affected the microsphere market in several ways. Supply chain disruptions, travel restrictions, and workforce shortages have led to operational challenges for microsphere manufacturers. The demand for microspheres, which are widely utilized in the automotive, cosmetics, and construction industries, has declined as a result of a reduction in consumer expenditure and construction projects. Furthermore, the healthcare industry was under pressure, and microsphere-related surgical procedures were put on hold, which gradually impeded this market growth.
The hollow segment is estimated to hold the largest share. These are utilized as lightweight fillers in materials such as concrete and coatings due to their low density. They are widely used in a variety of industries, including oil and gas, paints and coatings, composites, and materials whose strength-to-weight ratios can be enhanced by their lightweight nature. Furthermore, in medical applications, hollow microspheres serve as contrast agents in imaging techniques, providing enhanced visibility in diagnostic procedures.
The fly ash segment is anticipated to have highest CAGR during the forecast period. These microspheres act as lightweight fillers in concrete, enhancing its strength, durability, and insulation properties. Fly ash microspheres are used in drilling fluids in the oil and gas industry because of their lubricating and buoyant qualities. Furthermore, the fly ash microsphere market aligns with sustainable practices, as it involves repurposing industrial waste (fly ash) into valuable materials, contributing to waste reduction and environmental conservation, which are propelling this segment's growth.
Europe commanded the largest market share during the extrapolated period owing to the fact that the area is at the forefront of cutting-edge medical innovation and research, which has led to the development of innovative microsphere technologies for a range of healthcare uses. Personalized medicine, precision medication delivery, and the creation of biocompatible and biodegradable microspheres are some of these advancements. Furthermore, strict quality standards and regulatory regulations have been put in place as a result of Europe's technical breakthroughs, which are driving this region's growth.
Asia Pacific is expected to witness highest CAGR over the projection period. To encourage the usage and research of microsphere-based healthcare innovations, governments have launched programs and policies. In countries like China and India, the adoption of microspheres in lightweight concrete for infrastructure projects is on the rise. This region is home to major key players, including Siemens Healthineers AG, 3M, Kureha Corporation, and Potters Industries LLC, dedicated to sustainable healthcare solutions and technological advancement, which are boosting this region's growth.
Some of the key players in the Microspheres Market include 3M, Trelleborg AB, Bangs Laboratories Inc., Siemens Healthineers AG, Potters Industries LLC, Chase Corporation, Nouryon, Cospheric LLC, Mo-sci Corporation (Heraeus Holdings), Kureha Corporation, Momentive, Luminex Corporation (Diasorin Spa), Merit Medical Systems and Matsumoto Yushi-seiyaku Co. Ltd.
In August 2023, 3M announced it has completed the sale of certain assets from its dental local anesthetic portfolio, based in Seefeld, Germany, to Pierrel S.p.A., a global provider of services for the pharmaceutical industry, for a purchase price of $70 million, subject to closing and other adjustments.
In July 2023, Chase, announced that it has entered into a definitive agreement to be acquired by an affiliate of investment funds managed by KKR, a leading global investment firm.
In July 2023, 3M Health Information Systems (HIS) announced that U.S. News & World Report will incorporate the 3M™ Ambulatory Potentially Preventable Complications software in the analysis of its 2023-2024 Best Hospitals Specialty rankings.